Skip to main content
. 2019 Sep 30;33(6):2675–2684. doi: 10.1111/jvim.15608

Table 4.

Incidence of adverse events (based on all dogs treated with at least 1 dose of treatment; safety population)

Event Imepitoin (n = 114) (%) Placebo (n = 124) (%)
All adverse events 55 (48) 13 (10)
Ataxia 40 (35) 2 (2)
Increased appetite 21 (18) 1 (1)
Lethargy 14 (12) 2 (2)
Emesis 10 (9) 1 (1)
Hyperactivity 7 (6) 1 (1)
Somnolence 4 (3)

Events with >2.5% frequency are shown. Number of animals affected (at least 1 event).